MARSHALL WACE, LLP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$426,683
+41.9%
234,441
+295.3%
0.00%0.0%
Q4 2022$300,691
+17.5%
59,308
+15.0%
0.00%0.0%
Q3 2022$256,000
-70.3%
51,590
-66.3%
0.00%
-50.0%
Q1 2022$861,000
-41.9%
153,282
-37.1%
0.00%
-33.3%
Q4 2021$1,481,000243,5190.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders